Marianne Hupe - Publications

Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study.

Journal: Journal of Crohn's & colitis

Published: July 22, 2026

Prior exposure to advanced therapy and timing of discontinuation and risk of serious infections in patients with inflammatory bowel disease initiating a new advanced therapy.

Journal: Journal of Crohn's & colitis

Published: June 30, 2026

Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN®) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study.

Journal: Clinics and research in hepatology and gastroenterology

Published: May 28, 2026

Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID.

Journal: Clinics and research in hepatology and gastroenterology

Published: May 08, 2026

Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 28, 2026

Biologics and small molecules for perianal Crohn's disease: a systematic review and meta-analyses of randomized placebo-controlled trials.

Journal: Inflammatory bowel diseases

Published: February 14, 2026

Response to: Self-administered screening questionnaires for spondyloarthritis in inflammatory bowel disease: Methodological and conceptual gaps.

Journal: Seminars in arthritis and rheumatism

Published: January 04, 2026

Expert opinion on hot topics in the field of IBD.

Journal: Clinics and research in hepatology and gastroenterology

Published: October 27, 2025

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal

Published: October 19, 2025

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal

Published: October 19, 2025

Oral Gut-Restricted Targeted Therapy for IBD: A Pipeline Review.

Journal: Drugs

Published: October 15, 2025

Recurrent intra-mural esophageal abscess as a complication of untreated eosinophilic esophagitis.

Journal: Endoscopy

Published: August 14, 2025